211 related articles for article (PubMed ID: 31302152)
1. VISAGE Reveals a Targetable Mitotic Spindle Vulnerability in Cancer Cells.
Patterson JC; Joughin BA; Prota AE; Mühlethaler T; Jonas OH; Whitman MA; Varmeh S; Chen S; Balk SP; Steinmetz MO; Lauffenburger DA; Yaffe MB
Cell Syst; 2019 Jul; 9(1):74-92.e8. PubMed ID: 31302152
[TBL] [Abstract][Full Text] [Related]
2. The MTH1 inhibitor TH588 is a microtubule-modulating agent that eliminates cancer cells by activating the mitotic surveillance pathway.
Gul N; Karlsson J; Tängemo C; Linsefors S; Tuyizere S; Perkins R; Ala C; Zou Z; Larsson E; Bergö MO; Lindahl P
Sci Rep; 2019 Oct; 9(1):14667. PubMed ID: 31604991
[TBL] [Abstract][Full Text] [Related]
3. Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells.
Choi M; Kim W; Cheon MG; Lee CW; Kim JE
Cancer Lett; 2015 Feb; 357(2):591-601. PubMed ID: 25524551
[TBL] [Abstract][Full Text] [Related]
4. Plk1 inhibition leads to a failure of mitotic division during the first mitotic division in pig embryos.
Zhang Z; Chen C; Cui P; Liao Y; Yao L; Zhang Y; Rui R; Ju S
J Assist Reprod Genet; 2017 Mar; 34(3):399-407. PubMed ID: 28074435
[TBL] [Abstract][Full Text] [Related]
5. Identification of synthetic lethality of PLK1 inhibition and microtubule-destabilizing drugs.
Hugle M; Belz K; Fulda S
Cell Death Differ; 2015 Dec; 22(12):1946-56. PubMed ID: 26024389
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase 1 is essential for the first mitotic division in the mouse embryo.
Baran V; Solc P; Kovarikova V; Rehak P; Sutovsky P
Mol Reprod Dev; 2013 Jul; 80(7):522-34. PubMed ID: 23649868
[TBL] [Abstract][Full Text] [Related]
7. HSP70 colocalizes with PLK1 at the centrosome and disturbs spindle dynamics in cells arrested in mitosis by arsenic trioxide.
Chen YJ; Lai KC; Kuo HH; Chow LP; Yih LH; Lee TC
Arch Toxicol; 2014 Sep; 88(9):1711-23. PubMed ID: 24623308
[TBL] [Abstract][Full Text] [Related]
8. The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.
Aristizabal Prada ET; Orth M; Nölting S; Spöttl G; Maurer J; Auernhammer C
PLoS One; 2017; 12(5):e0178375. PubMed ID: 28542590
[TBL] [Abstract][Full Text] [Related]
9. The presumed MTH1-inhibitor TH588 sensitizes colorectal carcinoma cells to ionizing radiation in hypoxia.
Pompsch M; Vogel J; Classen F; Kranz P; Iliakis G; Riffkin H; Brockmeier U; Metzen E
BMC Cancer; 2018 Nov; 18(1):1190. PubMed ID: 30497423
[TBL] [Abstract][Full Text] [Related]
10. Validation and development of MTH1 inhibitors for treatment of cancer.
Warpman Berglund U; Sanjiv K; Gad H; Kalderén C; Koolmeister T; Pham T; Gokturk C; Jafari R; Maddalo G; Seashore-Ludlow B; Chernobrovkin A; Manoilov A; Pateras IS; Rasti A; Jemth AS; Almlöf I; Loseva O; Visnes T; Einarsdottir BO; Gaugaz FZ; Saleh A; Platzack B; Wallner OA; Vallin KS; Henriksson M; Wakchaure P; Borhade S; Herr P; Kallberg Y; Baranczewski P; Homan EJ; Wiita E; Nagpal V; Meijer T; Schipper N; Rudd SG; Bräutigam L; Lindqvist A; Filppula A; Lee TC; Artursson P; Nilsson JA; Gorgoulis VG; Lehtiö J; Zubarev RA; Scobie M; Helleday T
Ann Oncol; 2016 Dec; 27(12):2275-2283. PubMed ID: 27827301
[TBL] [Abstract][Full Text] [Related]
11. MTH1 Inhibitor TH588 Disturbs Mitotic Progression and Induces Mitosis-Dependent Accumulation of Genomic 8-oxodG.
Rudd SG; Gad H; Sanjiv K; Amaral N; Hagenkort A; Groth P; Ström CE; Mortusewicz O; Berglund UW; Helleday T
Cancer Res; 2020 Sep; 80(17):3530-3541. PubMed ID: 32312836
[TBL] [Abstract][Full Text] [Related]
12. TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model.
Moukengue B; Brown HK; Charrier C; Battaglia S; Baud'huin M; Quillard T; Pham TM; Pateras IS; Gorgoulis VG; Helleday T; Heymann D; Berglund UW; Ory B; Lamoureux F
EBioMedicine; 2020 Mar; 53():102704. PubMed ID: 32151797
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function.
Golsteyn RM; Mundt KE; Fry AM; Nigg EA
J Cell Biol; 1995 Jun; 129(6):1617-28. PubMed ID: 7790358
[TBL] [Abstract][Full Text] [Related]
14. Tubulin-associated drug targets: Aurora kinases, Polo-like kinases, and others.
Warner SL; Gray PJ; Von Hoff DD
Semin Oncol; 2006 Aug; 33(4):436-48. PubMed ID: 16890798
[TBL] [Abstract][Full Text] [Related]
15. Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.
Lin X; Chen D; Zhang C; Zhang X; Li Z; Dong B; Gao J; Shen L
J Exp Clin Cancer Res; 2018 Jun; 37(1):129. PubMed ID: 29954437
[TBL] [Abstract][Full Text] [Related]
16. Use of the novel Plk1 inhibitor ZK-thiazolidinone to elucidate functions of Plk1 in early and late stages of mitosis.
Santamaria A; Neef R; Eberspächer U; Eis K; Husemann M; Mumberg D; Prechtl S; Schulze V; Siemeister G; Wortmann L; Barr FA; Nigg EA
Mol Biol Cell; 2007 Oct; 18(10):4024-36. PubMed ID: 17671160
[TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase 1 inhibitors in mono- and combination therapies: a new strategy for treating malignancies.
Christoph DC; Schuler M
Expert Rev Anticancer Ther; 2011 Jul; 11(7):1115-30. PubMed ID: 21806334
[TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival.
Kawamura T; Kawatani M; Muroi M; Kondoh Y; Futamura Y; Aono H; Tanaka M; Honda K; Osada H
Sci Rep; 2016 May; 6():26521. PubMed ID: 27210421
[TBL] [Abstract][Full Text] [Related]
19. PLK1 inhibitors: setting the mitotic death trap.
Plyte S; Musacchio A
Curr Biol; 2007 Apr; 17(8):R280-3. PubMed ID: 17437704
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic mechanism of PLK1 inhibitor GSK461364 against osteosarcoma: Mitotic arrest, apoptosis, cellular senescence, and synergistic effect with paclitaxel.
Chou YS; Yen CC; Chen WM; Lin YC; Wen YS; Ke WT; Wang JY; Liu CY; Yang MH; Chen TH; Liu CL
Int J Oncol; 2016 Mar; 48(3):1187-94. PubMed ID: 26794530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
